Left Ventricular Assist Device (LVAD) Market Size Share Growth and Trends Value Report 2024-2031

Market Overview:

The global Left Ventricular Assist Device (LVAD) market reached a valuation of USD 1.4 billion in 2022 and is projected to grow to USD 2.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2023 to 2030. LVADs are mechanical circulatory support devices implanted in patients with severe heart failure, helping pump blood from the heart to the rest of the body. The rising incidence of heart failure, continuous product innovations, and increasing market developments are key drivers of this market's growth.

Market Trends:

Product and clinical study approvals are significant factors boosting the LVAD market. For instance, in October 2022, CARMAT received regulatory authorization from the French National Agency for Medicine and Health Product Safety (ANSM) and the Patient Protection Committee to restart the EFICAS Clinical Study. Similarly, in November 2021, CH Biomedical obtained authorization from the National Medical Products Administration (NMPA) for the CH-VAD left ventricular assist technique in China. These approvals are expected to accelerate market growth by expanding the availability of advanced LVAD products.

Research initiatives are presenting growth opportunities for the LVAD market. For example, Abbott reported in August 2022 that patients implanted with its HeartMate 3 LVAD exhibited better survival rates, which is expected to increase the adoption of such devices. Continuous research and development efforts are crucial in improving LVAD technologies and outcomes, thereby driving market growth.

Despite the advancements and increasing adoption of LVADs, the high cost of implantation is a significant barrier to market growth. According to the NIH, the average cost of LVAD implantation is USD 175,420. Although LVADs improve the quality of life for heart failure patients, they also lead to substantial lifetime costs due to frequent readmissions and costly follow-up care.

Download Sample: https://www.datamintelligence.com/download-sample/left-ventricular-assist-device-market

Market Segmentation:

The LVAD market is segmented by type, pump type, application, end-user, and region. The third-generation LVAD pump type segment is expected to dominate the global market, accounting for approximately 27.5% of the market share. This dominance is due to technological advancements in blood pumps, which now feature smaller dimensions, lighter weight, lower energy consumption, and increased durability. The third-generation LVADs, which use magnetic or hydrodynamic bearings, offer improved lifespan and reliability compared to earlier models.

Third-generation LVADs, characterized by non-contact pumps with magnetic or hydrodynamic bearings, are gaining traction due to their enhanced performance. These devices feature centrifugal pumps with active magnetic bearings for radial support and passive magnetic bearings for axial support. This design minimizes wear and tear, improving the device's longevity. Additionally, the integration of BLDC motors and eddy current-based gap sensors ensures precise rotor positioning and efficient operation.

Geographical Analysis:

North America is expected to hold approximately 38.8% of the LVAD market share by 2030. The region's dominance is attributed to the high prevalence of cardiovascular diseases, growing awareness, and the presence of major market players. According to the CDC, heart disease remains the leading cause of death in the U.S., with 699,659 deaths reported in 2022. Additionally, the Heart and Stroke Foundation of Canada highlights that over 100,000 Canadians are diagnosed with heart failure annually, a number that continues to rise. These factors underscore the significant demand for LVADs in North America.

To access the complete report: https://www.datamintelligence.com/research-report/left-ventricular-assist-device-market

Competitive Landscape:

The LVAD market is highly competitive, with several major players striving for market leadership. Key companies include:

CorWave, Apaxis Inc., Sunshine Heart, HeartWare International (Medtronic), Sun Medical Technology Research, Abiomed, Terumo Corporation, Evaheart, Jarvik Heart, Thoratec (Abbott).

Related Reports:

Extracorporeal Shock Wave Therapy Device Market: https://www.datamintelligence.com/research-report/extracorporeal-shock-wave-therapy-device-market

Female Urinary Incontinence Treatment Device Market: https://www.datamintelligence.com/research-report/female-urinary-incontinence-treatment-device-market

Femur Shaft Fracture Market: https://www.datamintelligence.com/research-report/femur-shaft-fracture-market

Surgical Sealants and Adhesives Market: https://www.datamintelligence.com/research-report/surgical-sealants-and-adhesives-market

Semi- Synthetic Surgical Sealants and Adhesives Market: https://www.datamintelligence.com/research-report/semi-synthetic-surgical-sealants-and-adhesives-market

Breast Cancer Liquid Biopsy Market: https://www.datamintelligence.com/research-report/breast-cancer-liquid-biopsy-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: DataMIntelligence

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.